{
    "clinical_study": {
        "@rank": "13364", 
        "arm_group": [
            {
                "arm_group_label": "golden crinkle", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "high blanch", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "low blanche", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "high chill", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "low chill", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "Potato is one of the world's most popular foods and is widely accepted as a staple food. The\n      objective of this study is to determine the effect of altering commercial blanching and\n      cooling times during manufacture of frozen fries produced by the on blood glucose, satiety\n      and appetite. It hypothesized that the processing regime predetermines the physiologic\n      responses to ingested product and therefore it is possible to produce healthier product\n      lines of potato fries."
        }, 
        "brief_title": "The Effect of Potato Fries Processing on Food Intake, Satiety and Blood Glucose", 
        "condition": [
            "Obesity", 
            "Overweight", 
            "Diabetes", 
            "Metabolic Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Overweight", 
                "Metabolic Syndrome X"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy men with a body mass index (kg/m2) of 20-24.9\n\n        Exclusion Criteria:\n\n          -  smocking, medication, breakfast skipping, restrained eating"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "December 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02014207", 
            "org_study_id": "Potato study 1: processing", 
            "secondary_id": "OMAFRA"
        }, 
        "intervention": {
            "arm_group_label": [
                "golden crinkle", 
                "high blanch", 
                "low blanche", 
                "high chill", 
                "low chill"
            ], 
            "intervention_name": "dietary treatment", 
            "intervention_type": "Other"
        }, 
        "lastchanged_date": "December 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5S 3E2"
                }, 
                "name": "Department of Nutritional Sciences"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "other_outcome": {
            "description": "Subjective appetite will be measured with visual analogue scales at 0 min immediately before the treatment (baseline) and at 15, 30, 45, 60, 90 and 120 min after the treatment.", 
            "measure": "subjective appetite", 
            "safety_issue": "No", 
            "time_frame": "120 min"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Ethics Review Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2007", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Glycaemic response will be measured before the treatment (baseline) and at 15, 30, 45, 60, 90 and 120 min after the treatment. The glucose concentration will be measured in capillary blood using portable glucose meter.", 
            "measure": "blood glucose", 
            "safety_issue": "No", 
            "time_frame": "120 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02014207"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Toronto", 
            "investigator_full_name": "G. Harvey Anderson", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Ad libidum food intake will be measure at 120 min using test pizza meal. The amount of consumed test meal (g) will be converted to the energy (kcal).", 
            "measure": "food intake", 
            "safety_issue": "No", 
            "time_frame": "120 min"
        }, 
        "source": "University of Toronto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Toronto", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}